GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Net Margin %

Ind-Swift Laboratories (NSE:INDSWFTLAB) Net Margin % : 6.75% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Ind-Swift Laboratories's Net Income for the three months ended in Dec. 2023 was ₹194 Mil. Ind-Swift Laboratories's Revenue for the three months ended in Dec. 2023 was ₹2,875 Mil. Therefore, Ind-Swift Laboratories's net margin for the quarter that ended in Dec. 2023 was 6.75%.

The historical rank and industry rank for Ind-Swift Laboratories's Net Margin % or its related term are showing as below:

NSE:INDSWFTLAB' s Net Margin % Range Over the Past 10 Years
Min: -18.07   Med: -1.54   Max: 3.94
Current: 3.62


NSE:INDSWFTLAB's Net Margin % is ranked better than
50.64% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.43 vs NSE:INDSWFTLAB: 3.62

Ind-Swift Laboratories Net Margin % Historical Data

The historical data trend for Ind-Swift Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Net Margin % Chart

Ind-Swift Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.83 -2.72 -0.35 -0.21 3.94

Ind-Swift Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.79 -8.26 5.56 10.93 6.75

Competitive Comparison of Ind-Swift Laboratories's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ind-Swift Laboratories's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Ind-Swift Laboratories's Net Margin % falls into.



Ind-Swift Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Ind-Swift Laboratories's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=475.966/12073.1
=3.94 %

Ind-Swift Laboratories's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=194.188/2875.143
=6.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift Laboratories  (NSE:INDSWFTLAB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Ind-Swift Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Traded in Other Exchanges
Address
SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101
Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines